Rivpra Formulations enters D2C market with a premium skincare brand, Oteria

March 8, 2025

Rivpra Formulation, an integrated pharmaceutical company, today announced its entry into the D2C segment with the launch of its latest venture – a premium skincare brand, Oteria. Built on the concept of ‘circadian rhythm,’ Oteria is a gender-neutral brand providing holistic skincare solutions for both men and women. With a comprehensive approach to skin, hair, and body care, Oteria has launched 19 products and plans to launch 30 more products by 2026. With these product lines, the company aims to focus on promoting awareness of skin nourishment based on one’s circadian rhythm.

With more than 20 years in the market, Rivpra Formulation merges pharmaceutical expertise with its very own state-of-the-art facility to research, test, develop, and innovate products within Oteria’s portfolio, in line with the human body’s natural rhythm.

Credit Source: Sugarmint

Topic: Pharma News, Pharma Press Releases

Company:

← Back to Articles

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

We use cookies to ensure you get the best experience. Learn more